- Price
Supplier Type
- Manufacturer
- Trader
- Reagent
- contract manufacturer
- custom synthesis
Supplier Region
- Bangalore(3)
- Gujarat(38)
- Mumbai(63)
- Maharashtra(43)
- New Delhi(4)
- Ahmedabad(13)
- Andhra Pradesh(1)
- Karnataka(5)
- Hyderabad(30)
- Delhi(8)
- Telangana(3)
- Pune(3)
- Vadodara(14)
- Uttar Pradesh(5)
- Nagpur(3)
- Madhya Pradesh(3)
- Haryana(4)
- Beijing(2)
- Kolkata(2)
- Tamil Nadu(4)
- Himachal Pradesh(1)
- Kerala(1)
- Punjab(3)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Potassium content 15.5 - 17.5
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- MIN. 99%
- Min 99%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Boron Content 2.0% - 4.0%
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.9%
- 99.9
- 99.86%
- 99.85%
- 99.80%
- 99.77%
- 99.73%
- 99.51%
- 99.50%
- ≥ 99.5%
- 99.5%
- 99.42%
- 99.30%
- 99.29%
- 99.00%
- 99%+
- 99% Pure
- 99% HPLC
- 99%
- >99%
- 99 %
- 98+
- 98.60%
- 98.30%
- 98.12%
- 98.00%
- 98%
- >98%
- 97-99%
- 97.57%
- 97.00%
- 97%
- >97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- 95.20%
- 95.00%
- >95%
- 95%
- 94.00%
- >92%
- >90%
- 90%
- 90 % Above
- 42%
- 12.6 % to 13.4 %
- 100%
- 0.5M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0KG
- 1g
- 5g
- 10g
- 25g
- 50g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 25gm
- 100
- 25
- 25mg
- 50mg
- 250mg
- 500mg
- 1gm
- 50
- 200
- 100mg
- 50gm
- 100ml
- 100g
- 100gm
- 200gm
- 250gm
- 500ml
- 500g
- 500gm
- 1L
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1and gm
- 1MT
- 50 gms
- 100 gms
- 250kgs
- 500gms
- 250250 mg.
-
(S)-4-(4-((3-amino-2-hydroxypropyl)amino)phenyl)morpholin-3-one hydrochloride
1403383-55-0
-
(S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid
1151893-81-0
-
1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]-
446292-08-6
-
Rivaroxaban Impurity 25
931117-61-2
-
1,3-bis(4-(3-oxomorpholino)phenyl)urea
1855920-51-2
-
3-MORPHOLINONE, 4-[4-[(5S)-5-(AMINOMETHYL)-2-OXO-3-OXAZOLIDINYL]PHENYL]-
446292-10-0
-
Rivaroxaban Impurity 27
1369969-44-7
-
2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-
1415566-28-7
-
(S)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxoMorpholino)phenyl)oxazolidin-5-yl)Methyl)thiophene-2-carboxaMide
1770812-37-7
-
Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-
1365267-35-1
Rivaroxaban Impurity 42 1403383-55-0
RIVAROXABAN IMPURITY 30 1369969-44-7
Reactive yellow 42 12226-63-0
Coconut diethanolamide 68603-42-9
L-Ephedrine 299-42-3
Acid Red 52 3520-42-1
Acid Yellow 42 6375-55-9
Direct yellow 86 50925-42-3
Alizarin Yellow 2G 584-42-9
4-Hydroxy-6-(3-sulfophenylamino)-2-naphthalenesulfonic acid 25251-42-7